You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev
SBC: Plant Vax, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): In the absence of specific intervention and with extended breast-feeding mother-to- child-transmission of HIV reaches a rate of ~35 % and infection of ~700,000 babies worldwide. Passive immunotherapy with a small numberof broadly neutralizing monoclonal antibodies (MAbs) in SHIV challenged macaques bodes well for the ability of infusion of neutralizing MAb to p ...
SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health -
Development of a low-cost hardware accelerator for 3D image registration
SBC: IGI TECHNOLOGIES, INC Topic: 102DESCRIPTION provided by applicant Our overall goal is to develop a novel computing solution for automatic and accurate registration spatial alignment of dimensional D medical images of any modality and any anatomy rigid or deformable in minute or less Such capability currently does not exist Existing image registration solutions have limited accuracy and or limited applicability p ...
STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health -
Attend BIO conference to meet with potential commercialization partners for ultra-fast MRI technology
SBC: WEINBERG MEDICAL PHYSICS, INC. Topic: NINDSDESCRIPTION provided by applicant This application represents a competing renewal request for a Phase II STTR project in which we constructed an ultra fast gradient system for magnetic resonance imaging Operation of the novel system is based upon the principle that the nervous system is relatively insensitive to very short exposures to changing magnetic fields As a result we are showing in ...
STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health -
TPM: A Voice-based Tele-PTSD Monitor
SBC: Intelligent Automation, Inc. Topic: OSD09H18Intelligent Automation proposes to develop voice-based automated Tele-PTSD Monitor (TPM), which can remotely screen, monitor, and provide assistance to clinicians in diagnosing a PTSD patient"s mental healthiness and readiness. A soldier (or other service man/women who may suffer from PTSD) can access the TPM system via a Public Switched Telephone Network (PSTN) or the Internet. The voice data is ...
SBIR Phase II 2011 Department of DefenseDefense Health Agency -
High Performance Signal Processing Tools with Fluctuation-Enhanced Sensing
SBC: Signal Processing, Inc. Topic: 9020163RWe propose a high performance library of signal processing tools that incorporate a newly developed technique known as fluctuation enhanced sensing (FES) to enhance the novel microsensor developed at NIST. Our goal is to improve the performance of the NIST sensor from two angles. One is to apply our existing proven algorithms to the NIST data. The other one is to incorporate advanced FES concept t ...
SBIR Phase I 2011 Department of CommerceNational Institute of Standards and Technology -
Anion Exchange Resins for Chirality-based Separation of Single-wall Carbon Nanotubes
SBC: Sepax Technologies, Inc. Topic: 9060663RSingle chirality of single-walled carbon nanotubes (SWCNTs) is critical for their superb mechanical, thermal, optical and electronic properties. All known methods for producing nanotubes give mixtures of tubes with different chiralities. Physical separation of SWCNT by chirality is thus an enabling step for many potential applications and fundamental studies. The existing anion exchange resins are ...
SBIR Phase I 2011 Department of CommerceNational Institute of Standards and Technology -
Enhanced Security Content Automation Protocol Editor
SBC: G2, INC. Topic: 9040577RG2 proposes to develop an intuitive, interactive SCAP content creation and editing utility that will provide a user-friendly operating environment. The promise of security automation offers the opportunity for great advances in software assurance, security governance/reporting, and ongoing monitoring activities. Hindering that promise is the fact that current data exchange protocols are cumbersome ...
SBIR Phase I 2011 Department of CommerceNational Institute of Standards and Technology -
Novel Targeted Therapy for Breast Cancer
SBC: A&G PHARMACEUTICAL, INC. Topic: NCIDESCRIPTION (provided by applicant): Breast cancer remains one of the top three cancers to affect and cause mortality in women. Major shortcomings with current treatment are the high level of side effects induced in patients and insufficient efficacy, particularly for patients with metastatic disease. Targeted cancer therapy is designed to treat only the cancer cells and minimize damage to healthy ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
A COMPANION DIAGNOSTIC FOR PROGNOSIS OF KIDNEY CANCER
SBC: 20 20 Genesystems Inc Topic: NCIThis contract was awarded by the National Cancer Institute's Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) Program under the funding opportunity "Contract Topic: 277 Companion Diagnostics: Predictive and Prognostic Tests Enabling Personalized Medicine in Cancer Therapy."
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
SBC: 20 20 Genesystems Inc Topic: NCIDESCRIPTION (provided by applicant): The promise of personalized medicine relies on the development of diagnostic tests to categorize patients within small cohorts who will benefit from specific treatments. 20/20 GeneSystems, Inc. (20/20) is a small business concern focused on the development of diagnostics for personalized medicine. Towards this end, 20/20 has developed, with the support of the N ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health